Compounds > n-acetylsphingosine

n-acetylsphingosine and Ovarian Neoplasms

n-acetylsphingosine has been researched along with Ovarian Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Appierto, V; Basso, L; Cavadini, E; Chigorno, V; Formelli, F; Loberto, N; Prinetti, A; Prioni, S; Sonnino, S; Valsecchi, M; Villani, MG	1
Altevogt, P; Condon, TP; Gast, D; Gutwein, P; Linderkamp, O; Marmé, A; Phong, MC; Riedle, S; Runz, S; Skorokhod, A; Stoeck, A	1
Altevogt, P; Gast, D; Gutwein, P; Issa, Y; Sanderson, MP; Stoeck, A	1
Dorrington, JH; Foghi, A; Ghahremani, M	1

Other Studies

4 other study(ies) available for n-acetylsphingosine and Ovarian Neoplasms

Article	Year
Altered sphingolipid metabolism in N-(4-hydroxyphenyl)-retinamide-resistant A2780 human ovarian carcinoma cells. The Journal of biological chemistry, 2003, Feb-21, Volume: 278, Issue:8 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Drug Resistance, Neoplasm; Female; Fenretinide; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Ovarian Neoplasms; Sphingolipids; Sphingosine; Tumor Cells, Cultured	2003
Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Apr-01, Volume: 11, Issue:7 Topics: ADAM Proteins; ADAM17 Protein; Amyloid Precursor Protein Secretases; Animals; Apoptosis; Ascitic Fluid; Aspartic Acid Endopeptidases; Binding, Competitive; Cell Hypoxia; Cell Line, Tumor; Cell Movement; CHO Cells; Cricetinae; Cricetulus; Cytoplasmic Vesicles; Endopeptidases; Extracellular Signal-Regulated MAP Kinases; Female; HeLa Cells; Humans; Metalloendopeptidases; Neural Cell Adhesion Molecule L1; Ovarian Neoplasms; Phosphorylation; Solubility; Sphingosine	2005
L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecologic oncology, 2007, Volume: 104, Issue:2 Topics: Animals; Apoptosis; Cell Line; Cell Line, Tumor; CHO Cells; Cisplatin; Cricetinae; Cricetulus; Female; Humans; Neural Cell Adhesion Molecule L1; Ovarian Neoplasms; Sphingosine; Staurosporine; Transfection	2007
Activation of Fas ligand/receptor system kills ovarian cancer cell lines by an apoptotic mechanism. Gynecologic oncology, 1998, Volume: 70, Issue:2 Topics: Antibodies, Monoclonal; Apoptosis; Enzyme Inhibitors; fas Receptor; Female; Humans; Hydrolysis; Ovarian Neoplasms; Receptors, Tumor Necrosis Factor; Sphingomyelins; Sphingosine; Tumor Cells, Cultured	1998